H1N1 countermeasure development

Ended Definitive Contract Awarded Jun 4, 2010 Last action Apr 27, 2018

Contract number: HDTRA110C0079
Awardee: Sarepta Therapeutics, Inc. UEI YKM9HZ3EH6X1 Part of Sarepta Therapeutics, Inc.
Awarding agency: Defense Threat Reduction Agency Department of Defense
Obligated: $12,324,641

Award facts

Opportunity: H1N1 Countermeasure Development Award Notice · Posted Aug 6, 2010
Contract value 94% obligated: $13,092,616.75 Current and potential, with all options
Completion date 100% complete: Jun 3, 2011 Current and potential, with all options
NAICS code: 541711 Research and Development in Biotechnology
PSC: AD92 R&D- Defense Other: Other (Applied Research/Exploratory Development)
Set-aside: No set-aside
Competition: Full and Open Competition · 1 offer Basic Research
Pricing: Cost Plus Fixed Fee
Place of performance: Corvallis, OR, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Other Administrative Action P00009	$137,000	Apr 27, 2018
Funding Only Action P00008	-$137,000	Sep 8, 2017
Funding Only Action P00007	-$767,976	Mar 14, 2012
Funding Only Action P00006	$92,617	Apr 28, 2011
Supplemental Agreement for work within scope P00005	$0	Apr 14, 2011
Funding Only Action P00004	$700,000	Apr 8, 2011
Funding Only Action P00003	$2,300,000	Apr 1, 2011
Definitize Letter Contract PZ0001	$0	Mar 3, 2011
Other Administrative Action P00002	$3,000,000	Dec 14, 2010
Other Administrative Action P00001 · Non-personal services	$0	Jun 29, 2010
Original award	$7,000,000	Jun 24, 2010

Show all 11

HDTRA110C0079 was awarded to Sarepta Therapeutics, Inc. by Defense Threat Reduction Agency (Department of Defense) on June 4, 2010.

The government has obligated $12,324,641 on HDTRA110C0079. Its current value, with exercised options, is $13,092,617.

The extent of competition for HDTRA110C0079 was full and open competition. The government received 1 offer.

On GovTribe

Try for free Login